Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Guido Tricot

Concepts (548)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
147
2024
2998
9.120
Why?
Hematopoietic Stem Cell Transplantation
28
2024
578
3.650
Why?
Pyrazines
20
2023
188
2.670
Why?
Antineoplastic Combined Chemotherapy Protocols
35
2024
1000
2.520
Why?
Boronic Acids
19
2014
183
2.470
Why?
Thalidomide
28
2023
378
2.440
Why?
Antineoplastic Agents
30
2020
1172
1.970
Why?
Transplantation, Autologous
30
2024
481
1.960
Why?
Transplantation Conditioning
9
2019
87
1.480
Why?
Drug Resistance, Neoplasm
17
2020
316
1.480
Why?
Paraproteinemias
8
2018
72
1.290
Why?
Humans
157
2024
50503
1.200
Why?
Neoplastic Stem Cells
5
2020
98
1.190
Why?
Protease Inhibitors
6
2011
58
1.080
Why?
Venous Thrombosis
7
2009
87
1.050
Why?
Melphalan
16
2023
178
1.010
Why?
Stem Cell Transplantation
13
2023
179
1.000
Why?
Angiogenesis Inhibitors
9
2009
183
1.000
Why?
Aged
58
2024
9741
0.950
Why?
Gene Expression Regulation, Neoplastic
13
2020
833
0.940
Why?
Hematopoietic Stem Cell Mobilization
5
2014
58
0.940
Why?
Prognosis
33
2024
1978
0.930
Why?
Middle Aged
60
2024
12611
0.890
Why?
Alkaline Phosphatase
5
2011
93
0.850
Why?
Busulfan
3
2019
19
0.850
Why?
Treatment Outcome
39
2022
5283
0.790
Why?
Plasma Cells
11
2023
221
0.780
Why?
Dexamethasone
16
2024
432
0.750
Why?
Male
68
2024
25907
0.700
Why?
Chromosome Aberrations
9
2008
280
0.670
Why?
Female
64
2024
27081
0.660
Why?
Thromboembolism
3
2009
55
0.660
Why?
Neoplasm Proteins
6
2021
320
0.630
Why?
Chromosomes, Human, Pair 13
6
2008
34
0.610
Why?
Disease-Free Survival
14
2019
444
0.580
Why?
Immunoglobulin Light Chains
3
2016
84
0.570
Why?
Survival Rate
18
2019
909
0.570
Why?
Bone Remodeling
2
2010
149
0.560
Why?
Anticoagulants
5
2009
256
0.560
Why?
Gene Expression Profiling
18
2023
1025
0.560
Why?
Blood Transfusion
1
2018
129
0.550
Why?
Immunologic Factors
5
2012
111
0.550
Why?
Cell Line, Tumor
18
2023
1398
0.530
Why?
Follow-Up Studies
21
2024
2242
0.520
Why?
Receptors, Retinoic Acid
2
2013
22
0.510
Why?
Antineoplastic Agents, Alkylating
7
2008
73
0.510
Why?
Proteasome Inhibitors
6
2018
104
0.500
Why?
IMP Dehydrogenase
2
2006
3
0.500
Why?
Mycophenolic Acid
2
2006
18
0.500
Why?
Clinical Trials as Topic
9
2022
486
0.490
Why?
Adult
38
2024
13577
0.490
Why?
Combined Modality Therapy
13
2008
641
0.480
Why?
Cell Proliferation
15
2020
985
0.470
Why?
Recurrence
16
2018
659
0.470
Why?
Antigens, Neoplasm
5
2007
148
0.460
Why?
Up-Regulation
5
2020
446
0.460
Why?
Apoptosis
9
2019
1097
0.460
Why?
Antibodies, Monoclonal
3
2015
462
0.450
Why?
Animals
30
2024
13124
0.450
Why?
Osteogenesis
3
2012
356
0.440
Why?
Retrospective Studies
18
2024
6263
0.440
Why?
Venous Thromboembolism
3
2011
74
0.440
Why?
Survival Analysis
12
2021
661
0.430
Why?
Disease Progression
12
2019
829
0.430
Why?
Signal Transduction
12
2020
1624
0.430
Why?
Doxorubicin
8
2018
236
0.430
Why?
Bone Diseases
3
2012
96
0.420
Why?
Neoplasms, Second Primary
2
2024
74
0.410
Why?
Thrombosis
4
2012
250
0.400
Why?
Central Nervous System Neoplasms
2
2004
63
0.400
Why?
T-Lymphocytes
10
2024
325
0.400
Why?
Myeloablative Agonists
5
2014
32
0.390
Why?
Bone Marrow
7
2022
363
0.390
Why?
Transplantation, Homologous
6
2004
145
0.380
Why?
Oligopeptides
2
2013
95
0.380
Why?
Osteoblasts
4
2007
462
0.370
Why?
Risk Factors
18
2018
3724
0.370
Why?
Hematopoietic Stem Cells
2
2010
197
0.370
Why?
Meta-Analysis as Topic
2
2015
38
0.360
Why?
Tumor Microenvironment
3
2024
222
0.350
Why?
Granulocyte Colony-Stimulating Factor
2
2008
63
0.350
Why?
Salvage Therapy
9
2012
137
0.350
Why?
Mice
19
2024
5687
0.350
Why?
Bone Marrow Transplantation
5
2007
136
0.340
Why?
Enzyme Inhibitors
2
2019
377
0.340
Why?
Membrane Proteins
4
2017
332
0.340
Why?
Monoclonal Gammopathy of Undetermined Significance
4
2024
112
0.340
Why?
Ultrasonography, Doppler
2
2007
41
0.340
Why?
Remission Induction
10
2008
208
0.330
Why?
Prospective Studies
9
2019
2378
0.330
Why?
Cell Cycle Proteins
2
2021
161
0.330
Why?
Neoplasm, Residual
4
2022
160
0.330
Why?
Myelodysplastic Syndromes
4
2007
78
0.320
Why?
B-Lymphocytes
4
2021
171
0.320
Why?
Waldenstrom Macroglobulinemia
3
2018
40
0.310
Why?
Lymphoma, B-Cell
3
2021
49
0.310
Why?
Immunosuppressive Agents
3
2005
225
0.310
Why?
Neovascularization, Pathologic
1
2009
155
0.300
Why?
Bone Neoplasms
1
2010
179
0.300
Why?
Killer Cells, Natural
4
2024
106
0.290
Why?
Brain Diseases, Metabolic
1
2007
4
0.280
Why?
Proteasome Endopeptidase Complex
4
2018
116
0.280
Why?
Chromosome Deletion
3
2008
134
0.280
Why?
Aged, 80 and over
11
2019
3226
0.280
Why?
Dose-Response Relationship, Drug
6
2016
1372
0.280
Why?
Hyperammonemia
1
2007
22
0.280
Why?
Amyloidosis
2
2007
81
0.280
Why?
Farnesyltranstransferase
1
2006
5
0.280
Why?
Research Design
1
2009
353
0.280
Why?
Thrombophilia
4
2009
18
0.270
Why?
Small Molecule Libraries
2
2019
67
0.270
Why?
Peripheral Blood Stem Cell Transplantation
4
2014
56
0.270
Why?
Hemostasis
1
2007
59
0.270
Why?
Bone and Bones
1
2010
478
0.270
Why?
Sirolimus
1
2006
62
0.260
Why?
Immunotherapy, Adoptive
4
2024
163
0.260
Why?
Gastrointestinal Neoplasms
1
2006
40
0.260
Why?
Cell Survival
8
2018
589
0.260
Why?
In Situ Hybridization, Fluorescence
6
2016
231
0.250
Why?
Caspases
1
2006
103
0.250
Why?
Flow Cytometry
6
2018
474
0.250
Why?
Diploidy
2
2004
26
0.240
Why?
beta 2-Microglobulin
5
2008
39
0.240
Why?
Antibody Formation
1
2005
50
0.240
Why?
Religion
1
2005
62
0.240
Why?
Activated Protein C Resistance
4
2011
10
0.240
Why?
Case-Control Studies
10
2018
1156
0.230
Why?
Aneuploidy
1
2004
18
0.230
Why?
Enoxaparin
1
2004
31
0.230
Why?
Ubiquitination
2
2021
42
0.220
Why?
Attitude to Health
1
2005
193
0.220
Why?
Adaptation, Psychological
1
2005
227
0.220
Why?
Osteolysis
2
2022
74
0.220
Why?
Multivariate Analysis
5
2008
583
0.220
Why?
Cancer Vaccines
3
2010
80
0.210
Why?
Cisplatin
6
2009
286
0.210
Why?
Cell Communication
2
2006
68
0.210
Why?
Pyrimidines
3
2015
191
0.210
Why?
Randomized Controlled Trials as Topic
4
2012
573
0.210
Why?
Blood Coagulation
1
2003
60
0.210
Why?
Mice, Inbred NOD
6
2020
91
0.210
Why?
Antigens, CD34
1
2003
75
0.210
Why?
Critical Illness
1
2005
302
0.210
Why?
Cytogenetic Analysis
6
2007
74
0.200
Why?
Graft vs Host Disease
5
2010
84
0.200
Why?
Parathyroid Hormone
3
2010
149
0.200
Why?
STAT3 Transcription Factor
4
2015
77
0.200
Why?
Cyclophosphamide
4
2003
168
0.200
Why?
Leukemia, Myeloid
1
2002
44
0.200
Why?
Kidney
1
2007
696
0.190
Why?
Bone Resorption
2
2022
302
0.190
Why?
Chromosome Disorders
1
2002
34
0.190
Why?
Etoposide
5
2009
77
0.190
Why?
Time Factors
9
2016
2935
0.190
Why?
Cyclin-Dependent Kinase Inhibitor p21
2
2015
67
0.190
Why?
Hypothyroidism
1
2002
56
0.190
Why?
Logistic Models
5
2018
900
0.190
Why?
Chromosomes, Human, Pair 1
3
2006
92
0.180
Why?
Antibodies, Bispecific
1
2022
88
0.180
Why?
Neoplasm Recurrence, Local
4
2024
629
0.170
Why?
Cytotoxicity, Immunologic
3
2012
55
0.170
Why?
Neoplasms
2
2009
1251
0.170
Why?
Xenograft Model Antitumor Assays
5
2019
212
0.170
Why?
DNA-Binding Proteins
2
2020
418
0.170
Why?
Glucuronidase
2
2018
48
0.170
Why?
Predictive Value of Tests
5
2009
930
0.160
Why?
Hematologic Neoplasms
2
2016
99
0.160
Why?
Proto-Oncogene Proteins c-bcl-2
2
2013
128
0.160
Why?
Cytokines
4
2007
606
0.160
Why?
Syndecan-1
3
2017
75
0.160
Why?
Osteoclasts
4
2022
427
0.160
Why?
Kaplan-Meier Estimate
6
2015
464
0.160
Why?
Healthcare Disparities
1
2022
281
0.160
Why?
Hydrocarbons, Aromatic
1
2018
2
0.160
Why?
Solvents
1
2018
29
0.150
Why?
Pyridines
1
2019
131
0.150
Why?
Drug Tolerance
1
2018
60
0.150
Why?
T-Lymphocytes, Cytotoxic
3
2010
63
0.150
Why?
Jehovah's Witnesses
1
2018
6
0.150
Why?
Dendritic Cells
3
2010
135
0.150
Why?
Vincristine
3
2003
82
0.150
Why?
Cell Differentiation
4
2022
640
0.150
Why?
Platelet Count
3
2008
65
0.150
Why?
CDC2-CDC28 Kinases
2
2015
11
0.150
Why?
Risk Assessment
5
2023
1270
0.140
Why?
Iron
2
2017
121
0.140
Why?
Occupational Diseases
1
2018
82
0.140
Why?
Interleukin-6
2
2018
261
0.140
Why?
Arsenicals
2
2010
14
0.140
Why?
Ascorbic Acid
1
2017
21
0.140
Why?
Pyruvate Kinase
1
2017
7
0.140
Why?
Oxides
2
2010
18
0.140
Why?
Drug Combinations
1
2017
127
0.140
Why?
Occupational Exposure
1
2018
113
0.140
Why?
Mice, SCID
5
2018
178
0.140
Why?
Anthropometry
1
2017
95
0.140
Why?
RNA Splicing
1
2017
38
0.130
Why?
Glycolysis
1
2017
69
0.130
Why?
Immunotherapy
4
2006
235
0.130
Why?
Transcription Factors
1
2020
565
0.130
Why?
Immunoglobulin lambda-Chains
1
2016
14
0.130
Why?
Factor V
3
2011
11
0.130
Why?
MicroRNAs
1
2020
344
0.130
Why?
Immunoglobulin kappa-Chains
1
2016
20
0.130
Why?
Fibrinolytic Agents
2
2007
125
0.130
Why?
Tumor Cells, Cultured
6
2019
457
0.130
Why?
Incidence
3
2009
1032
0.130
Why?
Leukocytes, Mononuclear
2
2014
118
0.130
Why?
Reproductive History
1
2015
4
0.130
Why?
Oncolytic Virotherapy
1
2015
18
0.130
Why?
Hormone Replacement Therapy
1
2015
33
0.120
Why?
Cyclopentanes
1
2015
10
0.120
Why?
Cell Adhesion Molecules
1
2015
86
0.120
Why?
Hemorrhage
2
2007
197
0.120
Why?
Ubiquitins
1
2015
39
0.120
Why?
Cation Transport Proteins
1
2015
27
0.120
Why?
Receptors, Cell Surface
1
2015
116
0.120
Why?
NF-kappa B
3
2018
315
0.120
Why?
Aldehyde Dehydrogenase
1
2014
25
0.120
Why?
Postmenopause
1
2015
96
0.120
Why?
Drug Monitoring
1
2015
79
0.120
Why?
Intestines
1
2016
172
0.120
Why?
Leukapheresis
1
2014
17
0.120
Why?
Translocation, Genetic
3
2005
240
0.120
Why?
Protein-Tyrosine Kinases
1
2015
88
0.110
Why?
Transplantation Chimera
3
2003
14
0.110
Why?
Myeloma Proteins
2
2020
26
0.110
Why?
Gene Deletion
3
2004
261
0.110
Why?
Antibodies
2
2024
153
0.110
Why?
Polymorphism, Single Nucleotide
1
2016
475
0.110
Why?
Receptor, Parathyroid Hormone, Type 1
1
2013
24
0.110
Why?
Veratrum Alkaloids
1
2013
5
0.110
Why?
Multidrug Resistance-Associated Proteins
1
2013
16
0.110
Why?
Body Mass Index
1
2017
677
0.110
Why?
Isoxazoles
1
2013
14
0.110
Why?
Biopsy
2
2006
588
0.110
Why?
Hedgehog Proteins
1
2013
32
0.110
Why?
Sulfones
1
2013
24
0.110
Why?
Cystatin M
2
2024
19
0.110
Why?
Itraconazole
1
2013
35
0.110
Why?
Genetic Predisposition to Disease
1
2016
511
0.110
Why?
Metaphase
3
2008
45
0.110
Why?
Carrier Proteins
2
2017
298
0.110
Why?
Intercellular Adhesion Molecule-1
1
2013
62
0.100
Why?
Wnt Proteins
1
2013
98
0.100
Why?
B-Cell Maturation Antigen
2
2024
99
0.100
Why?
Renal Insufficiency
3
2009
110
0.100
Why?
Risk
2
2011
324
0.100
Why?
Infusions, Intravenous
2
2003
213
0.100
Why?
Viremia
1
2012
22
0.100
Why?
Chromosomes, Human, Pair 11
2
2002
49
0.100
Why?
Drug Delivery Systems
2
2005
143
0.100
Why?
Cytomegalovirus Infections
1
2012
38
0.100
Why?
Clinical Trials, Phase II as Topic
1
2012
45
0.100
Why?
Radiopharmaceuticals
2
2021
204
0.100
Why?
Clinical Trials, Phase III as Topic
1
2012
45
0.100
Why?
Receptors, KIR
2
2008
13
0.100
Why?
Phosphorylation
2
2020
525
0.100
Why?
Fluorodeoxyglucose F18
2
2021
189
0.100
Why?
Medical Oncology
1
2012
98
0.090
Why?
Alcohol Drinking
1
2013
227
0.090
Why?
Ligands
2
2009
203
0.090
Why?
Reoperation
2
2004
460
0.090
Why?
Inflammation
1
2016
610
0.090
Why?
Drug Evaluation, Preclinical
1
2012
145
0.090
Why?
Age Factors
3
2005
1110
0.090
Why?
Tretinoin
2
2009
50
0.090
Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
1
2010
5
0.090
Why?
Smoking
1
2014
507
0.090
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2010
20
0.090
Why?
Recombinant Proteins
2
2010
476
0.090
Why?
Janus Kinase 1
1
2010
16
0.090
Why?
Antineoplastic Agents, Hormonal
2
2007
49
0.090
Why?
MAP Kinase Kinase 1
1
2010
23
0.090
Why?
Down-Regulation
2
2010
340
0.090
Why?
Cyclin-Dependent Kinases
1
2010
26
0.090
Why?
Macrophages
1
2013
364
0.090
Why?
Authorship
1
2010
12
0.080
Why?
Neoplasm Staging
3
2015
746
0.080
Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
80
0.080
Why?
Bone Density Conservation Agents
1
2010
74
0.080
Why?
Conflict of Interest
1
2010
25
0.080
Why?
Drug Industry
1
2010
38
0.080
Why?
Disclosure
1
2010
39
0.080
Why?
Diphosphonates
1
2010
90
0.080
Why?
Mice, Transgenic
3
2021
540
0.080
Why?
Chromosome Banding
2
2006
18
0.080
Why?
Leukocyte Count
2
2014
69
0.080
Why?
Plasmacytoma
2
2011
42
0.080
Why?
Periodicals as Topic
1
2010
58
0.080
Why?
Maximum Tolerated Dose
2
2009
39
0.080
Why?
Cell Cycle
2
2010
226
0.080
Why?
Oligonucleotide Array Sequence Analysis
5
2014
405
0.080
Why?
Magnetic Resonance Imaging
3
2007
1548
0.080
Why?
Cryoglobulinemia
1
2008
13
0.080
Why?
Blotting, Western
3
2015
578
0.080
Why?
Vascular Endothelial Growth Factor A
1
2009
182
0.080
Why?
Cytogenetics
1
2008
21
0.080
Why?
Prednisone
2
2009
101
0.080
Why?
Sulfonamides
1
2009
126
0.070
Why?
Polyethylene Glycols
1
2008
86
0.070
Why?
Pulmonary Embolism
1
2009
99
0.070
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2015
572
0.070
Why?
Neutrophils
2
2014
145
0.070
Why?
Immunophenotyping
2
2007
105
0.070
Why?
Hemoglobins
1
2008
109
0.070
Why?
Adoptive Transfer
1
2007
30
0.070
Why?
Heparin, Low-Molecular-Weight
1
2007
21
0.070
Why?
CD8-Positive T-Lymphocytes
2
2024
125
0.070
Why?
Histocompatibility Antigens Class I
1
2007
46
0.070
Why?
Phlebography
1
2007
60
0.070
Why?
Fibrinolysis
1
2007
5
0.070
Why?
Blood Coagulation Factors
1
2007
17
0.070
Why?
Ammonia
1
2007
78
0.070
Why?
Serum Albumin
2
2008
57
0.070
Why?
Chi-Square Distribution
1
2007
277
0.070
Why?
Biomedical Research
1
2010
244
0.070
Why?
Cell Membrane
1
2007
246
0.070
Why?
Brain
2
2007
1319
0.070
Why?
Drug Administration Schedule
2
2006
370
0.070
Why?
Osteoprotegerin
1
2006
54
0.070
Why?
Models, Genetic
1
2006
172
0.070
Why?
Guanosine
1
2006
5
0.070
Why?
Antibiotics, Antineoplastic
1
2006
77
0.060
Why?
Sex Factors
3
2016
712
0.060
Why?
Femur Head Necrosis
1
2005
18
0.060
Why?
Renal Dialysis
1
2007
171
0.060
Why?
Neovascularization, Physiologic
1
2005
68
0.060
Why?
Survivors
1
2006
128
0.060
Why?
Karyotyping
1
2005
65
0.060
Why?
Guanosine Triphosphate
1
2004
18
0.060
Why?
Gene Duplication
1
2005
14
0.060
Why?
Oncogene Proteins, Fusion
1
2005
57
0.060
Why?
Tissue Donors
2
2003
121
0.060
Why?
Kidney Transplantation
1
2007
189
0.060
Why?
Proteolysis
2
2015
96
0.060
Why?
Thrombophlebitis
1
2004
24
0.060
Why?
Genomic Instability
1
2005
90
0.060
Why?
Tomography, Emission-Computed
1
2004
53
0.060
Why?
Ferritins
1
2024
30
0.060
Why?
RNA Interference
2
2015
178
0.060
Why?
Myeloid Progenitor Cells
1
2023
17
0.060
Why?
X-Ray Microtomography
1
2024
79
0.060
Why?
Chromatography, High Pressure Liquid
1
2004
326
0.050
Why?
Patient Selection
1
2005
259
0.050
Why?
Stem Cell Factor
1
2003
7
0.050
Why?
Discitis
1
2003
11
0.050
Why?
Confidence Intervals
1
2003
154
0.050
Why?
Neoplastic Cells, Circulating
1
2004
74
0.050
Why?
Probability
1
2003
164
0.050
Why?
Lymphocyte Transfusion
1
2003
12
0.050
Why?
Anxiety
1
2005
285
0.050
Why?
Interferons
1
2002
38
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Cell Count
1
2003
150
0.050
Why?
Cyclosporine
1
2003
66
0.050
Why?
Drug Therapy, Combination
2
2017
384
0.050
Why?
Geography
1
2022
60
0.050
Why?
Tacrolimus
1
2003
53
0.050
Why?
Thyroid Function Tests
1
2002
25
0.050
Why?
Blood Group Incompatibility
1
2002
5
0.050
Why?
Stromal Cells
1
2002
75
0.050
Why?
Administration, Oral
1
2003
434
0.050
Why?
ABO Blood-Group System
1
2002
15
0.050
Why?
Thyrotropin
1
2002
49
0.050
Why?
Leukemia, Promyelocytic, Acute
1
2002
11
0.050
Why?
Drug Interactions
1
2002
206
0.050
Why?
Fatal Outcome
1
2002
197
0.050
Why?
Cell Division
1
2002
291
0.050
Why?
Chromosome Mapping
3
2006
153
0.050
Why?
Genomics
1
2023
279
0.050
Why?
Graft Survival
1
2002
159
0.050
Why?
Cells, Cultured
1
2005
1571
0.050
Why?
Acute Disease
1
2002
373
0.050
Why?
RANK Ligand
1
2022
187
0.050
Why?
Cluster Analysis
3
2006
219
0.040
Why?
Young Adult
3
2015
4102
0.040
Why?
Tomography, X-Ray Computed
1
2006
1164
0.040
Why?
Depression
1
2005
582
0.040
Why?
Neoplasm Transplantation
1
2020
86
0.040
Why?
Odds Ratio
2
2016
551
0.040
Why?
Pain
1
2003
387
0.040
Why?
3' Untranslated Regions
1
2020
52
0.040
Why?
Staphylococcal Infections
1
2003
267
0.040
Why?
Positron-Emission Tomography
1
2021
292
0.040
Why?
Postoperative Complications
1
2007
1033
0.040
Why?
Crystallography, X-Ray
1
2019
147
0.040
Why?
Antigens, CD
2
2015
222
0.040
Why?
Protein Conformation
1
2019
162
0.040
Why?
Mice, Nude
1
2019
248
0.040
Why?
Mice, Inbred BALB C
1
2019
296
0.040
Why?
Coculture Techniques
2
2012
142
0.040
Why?
Bone Marrow Cells
2
2015
196
0.040
Why?
Receptors, Interleukin-6
1
2018
22
0.040
Why?
Antigens, CD19
1
2018
29
0.040
Why?
Microarray Analysis
1
2018
70
0.040
Why?
Drug Resistance
1
2018
65
0.040
Why?
Disease Management
1
2020
178
0.040
Why?
Interferon-gamma
2
2010
177
0.040
Why?
Protein Stability
1
2018
43
0.040
Why?
Gene Knockdown Techniques
1
2018
105
0.040
Why?
Epidemiologic Methods
2
2008
46
0.040
Why?
Aerobiosis
1
2017
14
0.030
Why?
Microfilament Proteins
1
2017
42
0.030
Why?
Cross-Sectional Studies
1
2022
1610
0.030
Why?
HLA-A Antigens
2
2007
10
0.030
Why?
Thyroid Hormones
1
2017
20
0.030
Why?
Calcium-Binding Proteins
1
2017
55
0.030
Why?
Transplantation, Heterologous
1
2017
75
0.030
Why?
Polycomb Repressive Complex 1
1
2016
3
0.030
Why?
Vaccination
2
2010
280
0.030
Why?
Transmembrane Activator and CAML Interactor Protein
1
2016
6
0.030
Why?
Proto-Oncogene Proteins c-myc
1
2017
50
0.030
Why?
Genetic Loci
1
2016
45
0.030
Why?
Protein Binding
1
2018
654
0.030
Why?
Antibodies, Neoplasm
2
2006
28
0.030
Why?
Mice, Inbred ICR
1
2016
23
0.030
Why?
Mice, Knockout
1
2018
844
0.030
Why?
Microscopy, Electron, Transmission
1
2015
75
0.030
Why?
Reoviridae
1
2015
25
0.030
Why?
Genome-Wide Association Study
1
2016
163
0.030
Why?
Tumor Burden
1
2016
130
0.030
Why?
ras Proteins
1
2015
64
0.030
Why?
Repressor Proteins
1
2016
148
0.030
Why?
Receptors, Transferrin
1
2015
16
0.030
Why?
RNA, Messenger
2
2010
1089
0.030
Why?
Side-Population Cells
1
2015
3
0.030
Why?
Disease Models, Animal
2
2013
1436
0.030
Why?
Lentivirus
1
2015
17
0.030
Why?
Retinal Dehydrogenase
1
2014
10
0.030
Why?
Models, Biological
1
2018
716
0.030
Why?
Adenine
1
2015
31
0.030
Why?
Family
1
2016
178
0.030
Why?
Molecular Targeted Therapy
1
2016
123
0.030
Why?
Reactive Oxygen Species
1
2017
409
0.030
Why?
Cyclin B
1
2014
4
0.030
Why?
G2 Phase Cell Cycle Checkpoints
1
2014
9
0.030
Why?
CDC2 Protein Kinase
1
2014
16
0.030
Why?
Portraits as Topic
1
2014
2
0.030
Why?
Cell Lineage
1
2014
83
0.030
Why?
Mitosis
1
2014
88
0.030
Why?
Drug Synergism
1
2014
151
0.030
Why?
beta Catenin
1
2015
97
0.030
Why?
Piperidines
1
2015
99
0.030
Why?
Drug Screening Assays, Antitumor
1
2014
131
0.030
Why?
Pyrazoles
1
2015
111
0.030
Why?
Cell Movement
1
2015
247
0.030
Why?
Proportional Hazards Models
2
2006
415
0.030
Why?
Patient Safety
1
2014
102
0.030
Why?
Peptide Library
1
2013
16
0.030
Why?
Receptors, IgG
1
2013
22
0.030
Why?
Adolescent
2
2014
6443
0.030
Why?
Chromosomal Instability
1
2013
16
0.030
Why?
Epitopes
1
2013
59
0.030
Why?
Membrane Glycoproteins
2
2006
245
0.030
Why?
Protein Kinase Inhibitors
1
2014
204
0.030
Why?
Antibodies, Monoclonal, Murine-Derived
1
2012
45
0.030
Why?
Immunoglobulin M
1
2012
58
0.020
Why?
Interleukin Receptor Common gamma Subunit
1
2012
8
0.020
Why?
NK Cell Lectin-Like Receptor Subfamily K
1
2012
9
0.020
Why?
Cytomegalovirus
1
2012
28
0.020
Why?
Viral Load
1
2012
76
0.020
Why?
Peripheral Nervous System Diseases
1
2012
58
0.020
Why?
Interleukin-2
1
2012
71
0.020
Why?
Virus Activation
1
2012
37
0.020
Why?
Immunoenzyme Techniques
1
2012
137
0.020
Why?
Arkansas
2
2008
1985
0.020
Why?
Viper Venoms
1
2011
7
0.020
Why?
Asymptomatic Diseases
1
2011
37
0.020
Why?
Lymphocyte Activation
1
2012
164
0.020
Why?
Protein C
1
2011
18
0.020
Why?
Neoadjuvant Therapy
1
2012
120
0.020
Why?
Chemotherapy, Adjuvant
1
2011
121
0.020
Why?
Interferon Regulatory Factor-1
1
2010
14
0.020
Why?
Cell Growth Processes
1
2010
22
0.020
Why?
Antiviral Agents
1
2012
170
0.020
Why?
Immunoglobulin Idiotypes
1
2010
5
0.020
Why?
CD40 Ligand
1
2010
14
0.020
Why?
Hypersensitivity, Delayed
1
2010
19
0.020
Why?
Interleukin-4
1
2010
42
0.020
Why?
Immunity, Cellular
1
2010
63
0.020
Why?
Adjuvants, Immunologic
1
2010
51
0.020
Why?
Diagnosis, Differential
2
2004
1033
0.020
Why?
Mutation
1
2015
1280
0.020
Why?
Physician's Role
1
2010
48
0.020
Why?
RNA, Small Interfering
1
2010
208
0.020
Why?
Education, Medical, Continuing
1
2010
71
0.020
Why?
Practice Guidelines as Topic
1
2012
468
0.020
Why?
Hyperhomocysteinemia
1
2009
30
0.020
Why?
Protein Isoforms
1
2009
116
0.020
Why?
Indazoles
1
2009
46
0.020
Why?
Cytotoxicity Tests, Immunologic
1
2008
27
0.020
Why?
Safety
1
2009
77
0.020
Why?
Algorithms
1
2012
625
0.020
Why?
Vasculitis
1
2008
29
0.020
Why?
Haplotypes
1
2008
84
0.020
Why?
Ploidies
1
2008
11
0.020
Why?
Twins
1
2007
20
0.020
Why?
Double-Blind Method
1
2009
708
0.020
Why?
Age Distribution
1
2007
170
0.020
Why?
C-Reactive Protein
1
2008
144
0.020
Why?
Creatinine
1
2007
145
0.020
Why?
Multigene Family
1
2006
54
0.020
Why?
Blood Proteins
1
2007
84
0.020
Why?
Partial Thromboplastin Time
1
2006
12
0.020
Why?
Cyclin D
1
2006
18
0.020
Why?
Syndecans
1
2006
37
0.020
Why?
Heterozygote
1
2006
83
0.020
Why?
Cyclins
1
2006
38
0.020
Why?
RNA, Neoplasm
1
2006
43
0.020
Why?
Proteoglycans
1
2006
83
0.020
Why?
Amiloride
1
2005
8
0.020
Why?
HLA-A2 Antigen
1
2005
11
0.020
Why?
Cell Line
1
2008
988
0.020
Why?
Leukemia, Myeloid, Acute
1
2007
181
0.020
Why?
Transduction, Genetic
1
2005
46
0.020
Why?
Radiography
1
2007
485
0.020
Why?
Data Interpretation, Statistical
1
2006
162
0.020
Why?
Neoplasms, Experimental
1
2006
110
0.020
Why?
Interferon-alpha
1
2005
47
0.020
Why?
Sensitivity and Specificity
1
2007
859
0.020
Why?
Monocytes
1
2005
127
0.010
Why?
Databases, Factual
1
2007
673
0.010
Why?
Clone Cells
1
2004
70
0.010
Why?
Antibodies, Monoclonal, Humanized
1
2005
226
0.010
Why?
Monosomy
1
2003
5
0.010
Why?
Fibroblasts
1
2005
336
0.010
Why?
Trisomy
1
2003
27
0.010
Why?
History, 21st Century
1
2003
56
0.010
Why?
History, 20th Century
1
2003
100
0.010
Why?
Interphase
1
2003
9
0.010
Why?
Plasmapheresis
1
2003
11
0.010
Why?
Back Pain
1
2003
38
0.010
Why?
United States
1
2013
4955
0.010
Why?
Pore Forming Cytotoxic Proteins
1
2002
9
0.010
Why?
Perforin
1
2002
11
0.010
Why?
Anemia
1
2003
67
0.010
Why?
Cohort Studies
1
2006
1452
0.010
Why?
Antigen Presentation
1
2002
25
0.010
Why?
Red-Cell Aplasia, Pure
1
2002
7
0.010
Why?
Prevalence
1
2005
971
0.010
Why?
Quality Assurance, Health Care
1
2003
150
0.010
Why?
Erythrocyte Transfusion
1
2002
52
0.010
Why?
Cell Culture Techniques
1
2002
96
0.010
Why?
DNA, Neoplasm
1
2002
143
0.010
Why?
Graft Rejection
1
2002
172
0.010
Why?
Kidney Diseases
1
2003
213
0.010
Why?
Anti-Bacterial Agents
1
2003
745
0.010
Why?
Tricot's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description